Ginsenoside Rb1 ameliorates CKD-associated vascular calcification by inhibiting the Wnt/β-catenin pathway

Peng Zhou1, Xinyu Zhang1, Mengqi Guo1

  • 1The Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education, Chinese National Health Commission and Chinese Academy of Medical Sciences, The State and Shandong Province Joint Key Laboratory of Translational Cardiovascular Medicine, Department of Cardiology, Qilu Hospital of Shandong University, Jinan, China.

Insights

Ginsenoside Rb1 (Rb1) reduces vascular calcification in chronic kidney disease models by activating PPAR-γ and inhibiting the Wnt/β-catenin pathway. This study reveals Rb1

Area of Science:

  • Cardiovascular Biology
  • Nephrology
  • Pharmacology

Background:

  • Vascular calcification (VC) is a major contributor to cardiovascular disease morbidity and mortality.
  • Chronic kidney disease (CKD) is frequently associated with VC, highlighting the need for therapeutic targets.
  • The cardiovascular protective effects of Ginsenoside Rb1 (Rb1) are known, but its role in VC remains unexplored.

Purpose of the Study:

  • To investigate the therapeutic potential of Ginsenoside Rb1 (Rb1) in mitigating vascular calcification (VC).
  • To elucidate the underlying molecular mechanisms of Rb1's action in VC, particularly its interaction with the Wnt/β-catenin pathway.

Main Methods:

  • Established in vivo (CKD-associated VC rat model) and in vitro (β-glycerophosphate-induced VSMC calcification) models.
  • Administered Rb1 and assessed its effects on calcium deposition and VSMC osteogenic transdifferentiation.
  • Utilized confocal microscopy to observe β-catenin nuclear translocation and employed pathway modulators (SKL2001, GW9662) to confirm mechanisms.

Main Results:

  • Rb1 significantly ameliorated calcium deposition and prevented VSMC osteogenic transdifferentiation in both experimental models.
  • Rb1 activated peroxisome proliferator-activated receptor-γ (PPAR-γ), which subsequently inhibited the Wnt/β-catenin pathway by preventing β-catenin nuclear translocation.
  • Pharmacological inhibition of Wnt/β-catenin (SKL2001) diminished Rb1's protective effects, while PPAR-γ antagonism (GW9662) reversed Rb1's inhibition of β-catenin.

Conclusions:

  • Ginsenoside Rb1 (Rb1) demonstrates significant anticalcific properties in the context of chronic kidney disease-associated vascular calcification.
  • Rb1 exerts its protective effects by activating PPAR-γ, leading to the inhibition of the Wnt/β-catenin signaling pathway.
  • The findings suggest that the PPAR-γ/Wnt/β-catenin axis is a key mediator of Rb1's therapeutic action, offering new avenues for VC treatment.

Related Concept Videos

Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
10.4K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
8.3K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.5K
Catenins01:23

Catenins

Catenins are characterized by multiple binding domains and dynamic structures that allow them to function as linker proteins in cell junction complexes. All catenins, except α-catenin, contain a characteristic protein sequence called the armadillo repeat and are therefore also called armadillo proteins.
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the...
3.0K
Feedback Inhibition00:46

Feedback Inhibition

Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
56.9K
C4 Pathway and CAM01:27

C4 Pathway and CAM

Most plants use the C3 pathway for carbon fixation. However, some plants, such as sugar cane, corn, and cacti that grow in hot conditions, use alternative pathways to fix carbon and conserve energy loss due to photorespiration. Photorespiration is the process that occurs when the oxygen concentration is high. Under such conditions, the rubisco enzyme in the Calvin cycle binds O2 instead of CO2, which halts photosynthesis and consumes energy.
C4 Pathway
The C4 pathway is used by plants such as...
48.8K